MET Signaling Regulates Glioblastoma Stem Cells von KYEUNG MIN JOO, JIN, Juyoun, KIM, Hyunggee, HOJUNSEOL, KONG, Doo-Sik, LEE, Jung-Ii, RICH, Jeremy N, LEE, Jeongwu, NAM, Do-Hyun, KIM, Eunhee, KANG HO KIM, KIM, Yonghyun, BONG GU KANG, KANG, Youn-Jung, LATHIA, Justin D, KWANG HO CHEONG, SONG, Paul H

Volltext

A new anti-c-met antibody selected by a mechanism-based dual-screening method: Therapeutic potential in cancer von Oh, Y.M., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Song, Y.J., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Lee, S.B., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Jeong, Y.J., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Kim, B.G., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Kim, G.W., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Kim, K.E., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Lee, J.M., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Cho, M.Y., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Choi, J.H., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Nam, D.H., Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Republic of Korea, Song, Paul H, Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Cheong, K.H., Samsung Advanced Institute of Technology, Yongin, Republic of Korea, Kim, K.A., Samsung Advanced Institute of Technology, Yongin, Republic of Korea

Volltext

USP8 modulates ubiquitination of LRIG1 for Met degradation von Oh, Young Mi, Lee, Saet Byoul, Choi, Jaehyun, Suh, Hye-Young, Shim, Seonhui, Song, Yun-Jeong, Kim, Bogyou, Lee, Ji Min, Oh, Seung Ja, Jeong, Yunju, Cheong, Kwang Ho, Song, Paul H., Kim, Kyung-Ah

Volltext

Gln-362 of Angiopoietin-2 Mediates Migration of Tumor and Endothelial Cells through Association with α5β1 Integrin von Lee, Hyo Seon, Oh, Seung Ja, Lee, Kwang-Hoon, Lee, Yoon-Sook, Ko, Eun, Kim, Kyung Eun, Kim, Hyung-chan, Kim, Seokkyun, Song, Paul H., Kim, Yong-In, Kim, Chungho, Han, Sangyeul

Volltext

USP8 modulates ubiquitination of LRIG1 for Met degradation von Oh, Young Mi, Lee, Saet Byoul, Choi, Jaehyun, Suh, Hye-Young, Shim, Seonhui, Song, Yun-Jeong, Kim, Bogyou, Lee, Ji Min, Oh, Seung Ja, Jeong, Yunju, Cheong, Kwang Ho, Song, Paul H., Kim, Kyung-Ah

Volltext

Protein grafting of p53TAD onto a leucine zipper scaffold generates a potent HDM dual inhibitor von Lee, Jung-Hoon, Kang, Eunji, Lee, Jungmin, Kim, Jungmin, Lee, Kyoung Hu, Han, Jieun, Kang, Hye Yoon, Ahn, Soshin, Oh, Youngmi, Shin, Dongkyu, Hur, Kyeyeon, Chae, Su Young, Song, Paul H., Kim, Yong-In, Park, Jae Chan, Lee, Jae Il

Volltext

Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy von Kim, B, Wang, S, Lee, J M, Jeong, Y, Ahn, T, Son, D-S, Park, H W, Yoo, H-s, Song, Y-J, Lee, E, Oh, Y M, Lee, S B, Choi, J, Murray, J C, Zhou, Y, Song, P H, Kim, K-A, Weiner, L M

Volltext

Abstract CT178: GQ1001: A next generation HER2-targeting ADC that exhibits promising early clinical efficacy with excellent tolerance in a multi-center, Phase Ia study von Lemech, Charlotte, Zhou, Chenfei, Zhan, Xianbao, Shi, Yan, Liu, Jieqiong, Piha-Paul, Sarina A, Richardson, Gary, Qin, Gang, Song, Paul H., Shi, Lili, Sun, Yajun, Xia, Yi

Volltext

Abstract 1549: Preclinical characterization of GQ1010, a next generation Trop2 ADC with the best-in-class potential against diverse Trop2+ solid tumors von Sun, Yajun, Hu, Mingyu, Lv, Cao, Si, Yu, Liu, Xiao, Gao, Xinju, Yang, Dong, Chen, Guangming, Zhong, Boyu, Zhang, Tony, Shi, Lili, Qin, Gang, Song, Paul H.

Volltext

Abstract 2640: An innovative site-specific dual-payload antibody drug conjugate (dpADC) combining a novel Topo1 inhibitor and an immune agonist delivers a strong immunogenic cell d... von Xiong, Meijun, Fan, Beibei, Gao, Xinju, Sun, Yajun, Lv, Cao, Si, Yu, Liu, Xiao, Shi, Lili, Song, Paul H., Qin, Gang

Volltext

Abstract 2702: GQ1001 is a next generation HER2-targeting ADC with excellent druggability, safety and potency von Huang, Lei, Shi, Lili, Sun, Yajun, Lv, Cao, Gong, Chengcheng, Liu, Chong, Yang, Jun, Jiang, Lu, Yuan, Jinduo, Li, Xuesong, Hu, Mingyu, Gao, Xinju, Si, Yu, Yang, Hui, Shi, Yan, Yang, Bo, Song, Paul H., Qin, Gang, Wang, Biyun

Volltext

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY, AND USE THEREOF von QIN, Gang, SONG, Paul H, SUN, Yajun

Volltext bestellen

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND CANCER THERAPY, AND USE THEREOF von QIN, Gang, SONG, Paul H, SHI, LiLi

Volltext bestellen

ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF von QIN, Gang, SONG, Paul H, LIU, Chong

Volltext bestellen

Linkers, conjugates and applications thereof von Hu, Mingyu, Song, Paul H, Qin, Gang

Volltext bestellen

ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF von QIN, Gang, SONG, Paul H, LIU, Chong

Volltext bestellen

ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF von QIN, Gang, SONG, Paul H, LIU, Chong

Volltext bestellen

ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF von QIN, Gang, SONG, Paul H, LIU, Chong

Volltext bestellen

Antibody-immune agonist conjugate and applications thereof von Liu, Chong, Song, Paul H, Qin, Gang

Volltext bestellen

ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF von QIN, Gang, SONG, Paul H, LIU, Chong

Volltext bestellen